Medtronic (MDT) Curent Deferred Tax Liability (2014 - 2015)

Medtronic (MDT) reported Curent Deferred Tax Liability of $142.0 million for Q4 2015, up 18.33% sequentially from $120.0 million in Q3 2015.

Medtronic (MDT) Curent Deferred Tax Liability (2014 - 2015) Analysis & Trends

Medtronic (MDT) has 2 years of Curent Deferred Tax Liability data on file, last reported at $142.0 million in Q4 2015.

For the quarter ending Q4 2015, Curent Deferred Tax Liability changed N/A year-over-year to $142.0 million; the trailing twelve-month figure through Oct 2015 stood at $142.0 million (changed N/A YoY), and the FY2015 full-year result was $119.0 million, up 526.32% from the prior year.
Curent Deferred Tax Liability advanced to $142.0 million in Q4 2015, from $120.0 million in the prior quarter.
In the past five years, Curent Deferred Tax Liability ranged from a high of $142.0 million in Q4 2015 to a low of $19.0 million in Q2 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Curent Deferred Tax (Qtr)
1	Abbott Laboratories	183.06 Bn	175.76 Bn	6.27 Bn	-
2	Stryker	128.66 Bn	125.78 Bn	3.81 Bn	-
3	Medtronic	108.82 Bn	99.60 Bn	6.41 Bn	-
4	Boston Scientific	68.43 Bn	66.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	48.29 Bn	44.61 Bn	1.29 Bn	-
6	GE HealthCare Technologies	28.37 Bn	26.08 Bn	1.98 Bn	-
7	Dexcom	28.29 Bn	27.18 Bn	750.30 Mn	-
8	Smith & Nephew	26.89 Bn	26.31 Bn	-	-
9	Koninklijke Philips	25.43 Bn	22.31 Bn	2.07 Bn	-
10	Steris	21.52 Bn	21.08 Bn	697.10 Mn	-

Download Data